SVEGLIATI BARONI, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 10.859
EU - Europa 4.796
AS - Asia 4.534
SA - Sud America 1.027
Continente sconosciuto - Info sul continente non disponibili 436
AF - Africa 244
OC - Oceania 8
Totale 21.904
Nazione #
US - Stati Uniti d'America 10.617
SG - Singapore 1.451
VN - Vietnam 911
RU - Federazione Russa 854
IT - Italia 794
CN - Cina 785
BR - Brasile 762
UA - Ucraina 631
HK - Hong Kong 505
DE - Germania 484
IE - Irlanda 407
SE - Svezia 398
FR - Francia 321
FI - Finlandia 230
GB - Regno Unito 230
DK - Danimarca 202
TR - Turchia 181
IN - India 124
BD - Bangladesh 120
CA - Canada 116
KR - Corea 108
AR - Argentina 91
MX - Messico 74
MA - Marocco 61
CI - Costa d'Avorio 54
ZA - Sudafrica 51
IQ - Iraq 50
NL - Olanda 50
PL - Polonia 50
EC - Ecuador 47
JP - Giappone 47
ID - Indonesia 39
CO - Colombia 35
PK - Pakistan 32
UZ - Uzbekistan 29
AT - Austria 25
BE - Belgio 23
CL - Cile 23
VE - Venezuela 22
ES - Italia 20
PY - Paraguay 20
SA - Arabia Saudita 16
JO - Giordania 15
PH - Filippine 14
TN - Tunisia 13
DZ - Algeria 12
KE - Kenya 12
LT - Lituania 12
AZ - Azerbaigian 11
EG - Egitto 11
MY - Malesia 11
TT - Trinidad e Tobago 11
UY - Uruguay 11
KZ - Kazakistan 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
ET - Etiopia 9
JM - Giamaica 8
RS - Serbia 8
BO - Bolivia 7
CR - Costa Rica 7
RO - Romania 7
AU - Australia 6
EU - Europa 6
HN - Honduras 6
IL - Israele 6
KG - Kirghizistan 6
NP - Nepal 6
OM - Oman 6
PE - Perù 6
TW - Taiwan 6
AL - Albania 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
AM - Armenia 4
BG - Bulgaria 4
CG - Congo 4
CZ - Repubblica Ceca 4
GR - Grecia 4
LU - Lussemburgo 4
NG - Nigeria 4
PT - Portogallo 4
SN - Senegal 4
SV - El Salvador 4
BH - Bahrain 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
KW - Kuwait 3
LB - Libano 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
EE - Estonia 2
GY - Guiana 2
KH - Cambogia 2
MD - Moldavia 2
ME - Montenegro 2
SI - Slovenia 2
Totale 21.449
Città #
Ashburn 1.665
Singapore 883
Chandler 778
Jacksonville 653
Fairfield 593
San Jose 553
Hong Kong 495
Des Moines 460
Council Bluffs 438
Dallas 430
Dublin 404
Boardman 391
Ho Chi Minh City 326
Wilmington 288
New York 279
Woodbridge 268
Houston 253
Seattle 211
Los Angeles 206
Cambridge 190
Beijing 181
Hanoi 177
Centro 172
Munich 163
Lauterbourg 160
The Dalles 160
Princeton 154
Lawrence 152
San Mateo 144
Ann Arbor 142
Moscow 134
Helsinki 99
San Diego 89
Hefei 83
São Paulo 81
Milan 73
Guangzhou 71
Chicago 70
Santa Clara 65
London 63
Buffalo 56
Abidjan 54
Orem 53
Turin 51
Da Nang 39
Tokyo 37
Chennai 35
Ancona 34
Washington 34
Haiphong 33
Wuhan 33
Warsaw 31
Brooklyn 30
Rome 30
Turku 30
Montreal 28
Denver 27
Ottawa 27
Atlanta 26
Johannesburg 25
Tashkent 25
Mexico City 24
Poplar 24
Rio de Janeiro 24
Shanghai 24
Columbus 23
Miano 23
Frankfurt am Main 22
Norwalk 22
Nuremberg 22
Phoenix 22
Stockholm 22
Toronto 22
Baghdad 20
Boston 20
Pune 20
Redmond 20
Salt Lake City 20
Amsterdam 17
Brussels 17
Curitiba 16
Quito 16
Dhaka 15
Marche 15
Ankara 13
Belo Horizonte 13
Kraków 13
Amman 12
Bogotá 12
Bologna 12
Can Tho 12
Fayetteville 12
Guayaquil 12
Lahore 12
Miami 12
Mumbai 12
Salvador 12
San Francisco 12
Baku 11
Cape Town 11
Totale 13.598
Nome #
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 279
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 230
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 207
Adjuvant treatment with Capecitabine in patients who received orthotopic liver transplantation with incidental diagnosis of intrahepatic cholangiocarcinoma. Implications on DPYD polymorphisms assessment: report of two cases and review of the literature 198
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 196
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 193
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 186
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota 174
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 171
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 170
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 168
Acetaldehyde-collagen adducts in N-nitrosodimethylamine-induced liver cirrhosis in rats. 168
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 168
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 168
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 167
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 163
Predictors of Worse Prognosis in Young and Middle-Aged Adults Hospitalized with COVID-19 Pneumonia: A Multi-Center Italian Study (COVID-UNDER50) 163
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression from NAFLD to NASH 160
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 156
Immunological risk factors in biliary strictures after liver transplantation 156
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 155
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 154
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 151
Mechanisms for increased risk of diabetes in chronic liver diseases 151
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals 150
Leptin enhances cholangiocarcinoma cell growth. 149
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 148
Liver transplantation in patients with common variable immunodeficiency: a report of two cases 147
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 146
Hepatitis E in a region of Italy: An emerging autochthonous infection? 145
Gut-pancreas-liver axis as a target for treatment of nafld/nash 144
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 143
From the metabolic syndrome to NAFLD or vice versa? 142
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 141
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. 141
Years of life that could be saved from prevention of hepatocellular carcinoma 141
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 141
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 138
Tocilizumab in COVID-19 interstitial pneumonia 138
Cell proliferation following extrahepatic biliary obstruction. Evaluation by immunohistochemical methods. 137
Liver transplantation in neurological Wilson's Disease: is there indication? A case report 136
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 136
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 136
[L-sulpiride versus metoclopramide in functional dyspepsia: a randomized double-blind study] 135
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. 135
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 134
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. 134
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 133
Microwave ablation followed by cTACE in 5-cm HCC lesions: does a single-session approach affect liver function? 132
NERVE GROWTH FACTOR MODULATES THE PROLIFERATIVE CAPACITY OF THE INTRAHEPATIC BILIARY EPITHELIUM IN EXPERIMENTAL CHOLESTASIS. 132
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 132
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 131
Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. 130
Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease 130
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. 129
Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. 129
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 129
Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. 129
Effect of cyanidin 3-O-beta-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress. 128
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with nonalcoholic fatty liver disease 128
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 127
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 127
Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients 127
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C 126
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 126
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 125
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease 125
Lipotoxicity and the gut-liver axis in NASH pathogenesis 125
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 125
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 125
Therapy with direct-acting antiviral agents in transplanted patients with HCV recurrence: a retrospective analysis 124
Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen. 123
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. 123
Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area 123
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. 122
Observer agreement in endoscopic assessment of ulcerative colitis. 122
Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. 121
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. 121
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 121
Fibrogenic effect of oxidative stress on rat hepatic stellate cells. 120
Regulation of intracellular pH in isolated periportal and perivenular rat hepatocytes. 120
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 119
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis 119
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study 119
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 119
Intracellular pathways mediating Na+/H+ exchange activation by platelet-derived growth factor in rat hepatic stellate cells. 118
A 360-degree overview of paediatric NAFLD: Recent insights 118
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 118
Fibrogenesis in nonalcoholic steatohepatitis. 117
BILE ACIDS INDUCE HEPATIC STELLATE CELL PROLIFERATION VIA ACTIVATION OF THE EPIDERMAL GROWTH FACTOR 117
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 117
Effect of cyanidin 3-O-β-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress 114
Metabolic disorders across hepatocellular carcinoma in Italy 114
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. 113
Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. 113
Subcellular distribution and Nrf2/Keap1-interacting properties of Glutathione S-transferase P in hepatocellular carcinoma 112
Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E) 112
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 112
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 110
Simultaneous characterization of progenitor cell compartments in adult human liver. 109
Totale 13.969
Categoria #
all - tutte 106.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.235 0 330 39 31 8 52 84 80 80 95 196 240
2022/20232.538 199 257 164 187 154 645 0 132 541 14 177 68
2023/20241.462 239 37 94 272 218 289 23 55 10 44 17 164
2024/20253.015 307 257 123 39 92 186 318 143 606 326 269 349
2025/20268.687 534 566 426 1.023 980 625 1.477 851 731 788 249 437
2026/2027665 416 249 0 0 0 0 0 0 0 0 0 0
Totale 21.904